Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lilly’s Cyramza clears Phase III lung cancer trial

Metastatic lung cancer currently lacks cure and is associated with low survival rates. Credit: Librepath.



  • Lilly’s Cyramza clears Phase III lung cancer trial
Close
Close
Close

Go Top